The CEO of Eshmoun-Clinical Research, Dr Souad Dziri, was the guest speaker at the first International Congress of the Tunisian Society of Pharmacy and Oncology to discuss the role of CROs in setting up clinical trials during the second session of the day on the theme of Clinical Research in Oncology.
Eshmoun-Clinical Research, an academic CRO dedicated to Clinical Research, is committed to implementing a training strategy dedicated to the clinical research professions.
In partnership with the Medical Simulation Center, Eshmoun Clinical Research offered its first Clinical Research Associate training course from March 11 to March 29.
National experts in clinical research shared their experience with the students. These included Pr Hechmi Louzir, Pr Chadli Dziri, Dr Chokri Jeribi, Pr Chawki Gueddas, Dr Myriam Guerfali, Pr Samir Boubaker…
The students were also accompanied by international experts such as Pr Faiez Zannad and Drs Cecile Dolinger and Stephanie Grojean.
Eshmoun Clinical-Research thus confirms its commitment to promoting medical research in Tunisia and its position as an academic CRO.
Similar training courses for the various clinical research professions and independent modular training courses are planned from September 2019.
Eshmoun-Clinical Research held its launch ceremony on April 19, 2019 at the Dar El Jeld Hotel in the Medina of Tunis.
At the ceremony, the Eshmoun management board presented its missions and remit across the Africa – Middle East region. The ceremony was distinguished by the quality of its audience, which included the Minister of Health, the relevant departments of the Tunisian Ministry of Health, general managers of public structures, learned societies, international and national experts in clinical research, and the local and international pharmaceutical industry.
Round table on “The state of play, challenges and prospects for immunotherapy in Tunisia” organized at the BiotechPole Sidi Thabet in conjunction with the celebration of World Immunology Day (April 29, 2019) and in collaboration with the Tunisian Immunology Society.
A highly enriching debate was witnessed, animated by the presence of various players in the field, including Dr Souad Dziri, CEO ofEshmoun Clinical-Research, as well as academics, researchers, public authorities, industrialists, doctors and patients.